Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) EV/FCF
As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a EV/FCF of 25.6×. Over the past ten years it has ranged from 0.0× (September 2024) to 50.1× (September 2025); the current reading is higher than 14% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 22.9× | (26.10%) |
| FY2024 | 31.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 26.3× | (19.20%) |
| Jun 2026 | 32.6× | (2.88%) |
| Mar 2026 | 33.6× | 46.39% |
| Dec 2025 | 22.9× | (4.22%) |
| 8 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| BKD Brookdale Senior Living Inc. compare | −46.1× |
| MD Pediatrix Medical Group, Inc. compare | 12.4× |
| ADUS Addus HomeCare Corporation compare | 15.5× |
| NHC National HealthCare Corporation compare | 17.1× |
| GRDN Guardian Pharmacy Services, Inc. | 25.6× |
| ASTH Astrana Health, Inc. compare | 25.9× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 27.4× |
| SGRY Surgery Partners, Inc. compare | 34.1× |
| ACHC Acadia Healthcare Company, Inc. compare | 499× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement